Celesevelam

Colesevelam is a bile acid sequestrant administered orally. It was developed by GelTex Pharmaceuticals and later acquired by Genzyme. It is marketed in the US by Daiichi Sankyo under the brand name Welchol and elsewhere by Genzyme as Cholestagel. In Canada it is marketed by Valeant as Lodalis

A Anant Labs fabrica e fornece impurezas de Celesevelam de alta qualidade para o mercado global. Nossas impurezas EP de Celesevelam são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.